Department of Radiation Oncology, Gustave Roussy Institute, Paris XI University, Villejuif, France.
Anticancer Res. 2012 Sep;32(9):4025-7.
Despite new aggressive therapeutical options for advanced malignant pleural mesothelioma (MPM), benefits to survival remain limited. Moreover, deleterious effects of high-dose chemotherapy and aggressive surgery are well-known. Outcomes of untreated patients are usually not reported, and whether a treatment can be delayed or avoided is still an open question. We discuss here two clinical cases and with conservative (palliative) management alone for advanced MPM [corrected].
尽管对于晚期恶性胸膜间皮瘤（MPM）有新的积极治疗选择，但生存获益仍然有限。此外，大剂量化疗和激进手术的有害影响是众所周知的。未经治疗的患者的结果通常不被报道，并且是否可以延迟或避免治疗仍然是一个悬而未决的问题。在这里，我们讨论了两个临床病例，并单独采用保守（姑息）治疗晚期 MPM[已更正]。
